Taken together, our results provide insights into the roles of gram-negative bacteria in gut-generated LPS and intracellular gram-negative bacterial infections in CKD and hyperlipidemia pathologies activating CASP4/11-GSDMD and IL1B pathways. This evidence concerns the gene CASP4 and gram-negative bacterial infections.